Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd.
- Market cap
- $1.09B
Your view on DRTS
Overview
What the company does, where it operates, and who runs it.
About Alpha Tau Medical Ltd.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Uzi Sofer
- Headquarters
- 5 Kiryat Hamada Street, Jerusalem, IL
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Uzi Sofer
- Headquarters
- 5 Kiryat Hamada Street, Jerusalem, IL
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States.
Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
Stock Data
Price chart, volume, and trading data.
What moved it
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Alpha Tau Medical Ltd.. Starting points for Alpha Tau Medical Ltd.: EPS -$1.20, beta 1.29 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Alpha Tau Medical Ltd.. Trailing twelve-month EPS for Alpha Tau Medical Ltd. stands at -$1.20. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Buy
Targets, low to high
Analyst ratings
5 firms, last 12 months- Strong Buy0
- Buy5
- Hold0
- Sell0
- Strong Sell0
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | −$0.15 | −$0.15 | −$1.07 | −$0.54 |
| Lowest estimate | −$0.15 | −$0.15 | −$1.08 | −$0.59 |
| Highest estimate | −$0.15 | −$0.14 | −$1.05 | −$0.49 |
| Number of analysts | 2 | 2 | 2 | 4 |
| A year ago | −$0.14 | −$0.261 | −$0.53 | — |
| Growth vs a year ago | −7.1% | — | −101.5% | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | $250000.00 | $533333.00 | $375000.00 | $10.72M |
| Lowest estimate | $250000.00 | $533333.00 | $375000.00 | $10.72M |
| Highest estimate | $250000.00 | $533333.00 | $375000.00 | $10.72M |
| Number of analysts | 2 | 2 | 2 | 2 |
| A year ago | $0.00 | $0.00 | $0.00 | — |
| Growth vs a year ago | — | — | — | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Alpha Tau Medical Ltd.. Alpha Tau Medical Ltd. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| CATXPerspective Therapeutics, Inc. | Healthcare | Medical - Devices | $91.0M | ||
| RADXRadiopharm Theranostics Limited | Healthcare | Biotechnology | $812,081 | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CKDXFOpthea Limited | Healthcare | OTC | $601.9M | ||
| CLAZFClaritas Pharmaceuticals, Inc. | Healthcare | OTC | $3,659 | ||
| CLCSCell Source, Inc. | Healthcare | OTC | $24.5M | ||
| CLDICalidi Biotherapeutics, Inc. | Healthcare | AMEX | $1.6M | ||
| CLDXCelldex Therapeutics, Inc. | Healthcare | NASDAQ | $2.2B | ||
| CLGNCollPlant Biotechnologies Ltd. | Healthcare | NASDAQ | $8.8M | ||
| CLLSCellectis S.A. | Healthcare | NASDAQ | $92.8M | ||
| CLNNClene Inc. | Healthcare | NASDAQ | $50.7M | ||
| CLRBCellectar Biosciences, Inc. | Healthcare | NASDAQ | $8.0M | ||
| CLVLFClinuvel Pharmaceuticals Limited | Healthcare | OTC | $424.1M | ||
| CLYMClimb Bio, Inc. | Healthcare | NASDAQ | $539.8M | ||
| CLYYFCelyad Oncology S.A. | Healthcare | OTC | $6.7M | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| IEFAiShares Core MSCI EAFE ETF | $188.8B in assets | 0.00% | |
| SCZiShares MSCI EAFE Small-Cap ETF | $12.6B in assets | 0.02% | |
| IZRLARK Israel Innovative Technology ETF | $126M in assets | 1.37% | |
| EISiShares MSCI Israel ETF | $808M in assets | 0.20% | |
| IXUSiShares Core MSCI Total International Stock ETF | $56.4B in assets | 0.00% | |
| EHLSEven Herd Long Short ETF | $54M in assets | 0.54% | |
| ZESM.TOBMO MSCI EAFE Small-Mid Cap Index ETF | $474M in assets | 0.02% | |
| IDEViShares Core MSCI International Developed Markets ETF | $33.4B in assets | 0.00% | |
Largest holders first, then the funds most concentrated in DRTS.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Alpha Tau Medical Ltd., and how their positions are changing. At a $1.09B market value, institutional positions materially move Alpha Tau Medical Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Alpha Tau Medical Ltd. executives and directors. Shares of Alpha Tau Medical Ltd. have traded between $2.20 and $4.69 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Alpha Tau Medical Ltd.. Coverage tracks Alpha Tau Medical Ltd. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Alpha Tau Medical Ltd.